Join

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · 3-min delay · Sign up for real-time

  • Atossa Therapeutics Inc. logo
    PR··Health Care·
    Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in ER-Positive Breast Cancer

    Peer-reviewed preclinical study published in npj Breast Cancer identifies new chemical entities with activity in ESR1-mutant models Findings suggest potential for combination with abemaciclibSEATTLE, July 28, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of significant unmet clinical need, today announced the publication of a peer-reviewed preclinical study in npj Breast Cancer evaluating five novel chemical entities structurally related to (Z)-endoxifen. The study titled, "Novel (Z)-endoxifen-related new chemical entities exhibit potent anti-cancer ac

  • Trio-Tech International logo
    PR··Technology·
    Trio-Tech International Receives Additional $3.8 Million in Orders Supporting Next-Generation AI GPU Platform

    Brings Total Announced Orders Supporting the Platform Since March to Approximately $14.2 Million Trio-Tech International (NYSE MKT : TRT), a comprehensive provider of semiconductor back-end solutions and a global value-added supplier of electronic equipment, today announced it has received approximately $3.8 million in additional orders for high-performance Burn-In Boards ("BIBs") supporting a next-generation artificial intelligence ("AI") GPU platform. The new orders follow previously announced orders of approximately $5.3 million in March 2026, $2.5 million in May and $2.6 million in June 2026, bringing total announced orders supporting the AI GPU platform since March to approximately

  • Rocket Companies Inc. logo
    PR··Finance·
    Redfin Reports 15% Fewer Canadians Are Searching for Homes in the U.S. Than Last Year

    Over the last two years, Canadian searches for U.S. homes have dropped roughly 37%.Canada-based home searches declined in 45 of the 50 most populous U.S. metros, with the biggest drops in San Antonio (-51.8%), Austin (-48.6%), Nassau County, NY (-33.4%) and Houston (-32.5%).The number of Canada-based Redfin.com users searching for U.S. homes to buy or rent fell 15.3% year over year in June, according to a new report from Redfin, the real estate brokerage powered by Rocket. That compares with a 10.1% decline in May.Over the past two years, Canadian searches for U.S. homes have dropped roughly 37%, after posting a 25.7% year-over-year decline in June 2025.Redfin search data is an early indicat

  • Momentus Inc. logo
    PR··Industrials·
    Momentus’ Vigoride 8 Spacecraft Successfully Completes Critical Design Review Milestone for 2027 Mission Launch

    Scheduled to carry two advanced NASA-hosted payloads in orbit Momentus Inc. (NASDAQ:MNTS) ("Momentus" or the "Company"), a U.S. commercial space company specializing in satellite technology, space transportation, and in‑orbit services, today announced the successful completion of the Spacecraft Critical Design Review (CDR) for its Vigoride 8 mission, transporting two hosted payloads under contracts with NASA. Successful completion of this key program milestone formally concludes the design and analysis phase of the preparation of the spacecraft. "Achieving Spacecraft CDR is a major accomplishment for the Vigoride 8 team," said Tom Malko, Senior Vice President of Engineering and Operatio

  • AngioDynamics Inc. logo
    PR··Health Care·
    AngioDynamics to Participate in Upcoming Investor Conferences

    AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that its management team is scheduled to participate in the following upcoming investor conferences: 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference Monday, August 10, 2026 Canaccord Genuity's 46th Annual Growth Conference Presentation: Tuesday, August 11, 2026 from 3:30-3:55 PM ET A live webcast of the presentation will be accessible through the "Investors" section of the Company’s website at www.angiodynamics.com. Abou

  • QT Imaging Holdings Inc. logo
    PR··Health Care·
    QT Imaging Receives Israeli Ministry of Health Regulatory Registration

    Regulatory approval enables commercialization of QT Imaging's technology in Israel and supports expansion of clinical research collaborations QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that the Israeli Ministry of Health has granted registration for the Company's scanner, authorizing commercialization of the system in Israel through February 2, 2028. The approval is based on the Company's existing U.S. FDA clearance and applicable Israeli regulatory requirements. QT Imaging’s Breast Acoustic CT™ Scanner produces t

  • Ambiq Micro Inc. logo
    PR··Technology·
    Ambiq Micro to Report Second Quarter 2026 Financial Results

    Ambiq Micro, Inc. (NYSE:AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced that it will report its second quarter 2026 financial results on Tuesday, August 11, 2026 before the market opens. The Company will host a conference call at 7:30 a.m. Central Time (8:30 a.m. Eastern Time) to discuss the results. Analysts and investors are invited to join the live conference call using the following information: Date: Tuesday, August 11, 2026 Time: 7:30 a.m. Central Time (8:30 a.m. Eastern Time) Webcast Link: https://events.q4inc.com/attendee/195766563 Conference Call Number: (833) 461-5787 International Call Number: +1 (585) 542-9983 Conference

  • CVRx Inc. logo
    PR··Health Care·
    CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference

    MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ:CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management team will present at Canaccord Genuity's 46th Annual Growth Conference in Boston on Tuesday, August 11, 2026. The Company's presentation will begin at 1:00 p.m. (ET). A live webcast of the event can be found at ir.cvrx.com. An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time. About CVRx, Inc. CVRx is a com

  • Relmada Therapeutics Inc. logo
    PR··Health Care·
    Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer

    Brings nearly three decades of leadership spanning NMIBC, corporate strategy and business development to help advance NDV-01 and support the Company's long-term growth and value creation. CORAL GABLES, Fla., July 28, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company")), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced the appointment of Bipin Dalmia, PhD, MBA, as Chief Business Officer. Bipin will lead Relmada's corporate strategy, commercial planning, and business development activities, reporting directly to Chief Executive Officer Sergio Traversa. Bipin

  • DENTSPLY SIRONA Inc. logo
    PR··Health Care·
    Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship

    CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, today announced an expansion of its long-standing relationship with Medline Sinclair, one of Canada's leading full-service dental distributors. Effective September 1, 2026, Medline Sinclair will begin offering Dentsply Sirona's technology portfolio across Canada, building on a successful relationship that has historically focused on consumables. The expanded relationship increases access to Dentsply Sirona's digital dentistry solutions through Medline Sinclair's nationwide network of sales, service teams, and technical specialis

  • LPL Financial Holdings Inc. logo
    PR··Finance·
    LPL Financial’s Latitude Unifies Technology Built for the Future of Advice

    SAN DIEGO, July 28, 2026 (GLOBE NEWSWIRE) -- LPL Financial LLC today announced LPL Latitude, the company’s unified technology experience that connects the firm’s capabilities across data, cybersecurity, infrastructure resiliency, artificial intelligence, advisor workflows and end-investor applications. "LPL Latitude is more than a technology system — it’s a strategic investment in the future of advice," said Rich Steinmeier, CEO of LPL Financial. "By creating a unified foundation across our business, we are accelerating innovation, unlocking the power of AI and data, and delivering more seamless, intelligent experiences for advisors and their clients. As the industry evolves, this integra

  • Neuronetics Inc. logo
    PR··Health Care·
    Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

    MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that it plans to release second quarter 2026 financial and operating results prior to market open on Tuesday, August 11, 2026. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day. The conference call will be broadcast live in listen-only mode via webcast at https://edge.media-server.com/mmc/p/7ri4xna9. To listen to the conference call on your telephone, participants may

  • Cheniere Energy Partners, LP logo
    PR··Public Utilities·
    Cheniere Partners Declares Quarterly Distributions

    Cheniere Energy Partners, L.P. ("Cheniere Partners") (NYSE:CQP) today declared (i) a cash distribution of $0.820 per common unit to unitholders of record as of August 7, 2026, comprised of a base amount equal to $0.775 and a variable amount equal to $0.045, and (ii) the related distribution to its general partner. These distributions are payable on August 14, 2026. Publicly traded partnerships that earn net income in a calendar year that is effectively connected with the conduct of a US trade or business are generally required to withhold US income tax from distributions paid to foreign persons. The portion of our quarterly cash distributions that are paid to foreign persons will generall

  • Bicara Therapeutics Inc. logo
    PR··Health Care·
    Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors

    BOSTON, July 28, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (NASDAQ:BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced the appointments of Jeremy Bender, Ph.D., MBA and Christy Oliger to its Board of Directors. Dr. Bender, who most recently served as Chief Executive Officer at Day One Biopharmaceuticals through its acquisition by Servier in 2026, brings more than 20 years of corporate strategy and operating experience in biotechnology to Bicara. Ms. Oliger brings more than 30 years of commercial and operating experience in global biopharmaceutical organizations, having most rece

  • RenX Enterprises Corp. logo
    PR··Finance·
    RenX Enterprises Launches Land Clearing Division and Wins First Purchase Order

    MIAMI, FL, July 28, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corp. (NASDAQ:RENX) ("RenX" or the "Company") today announced the launch of its land clearing division and the receipt of the division's first purchase order. The purchase order was issued by a regional land development company and covers land clearing services at a project site in Florida. Work under the purchase order is expected to commence shortly. The land clearing division captures value on both sides of the same material stream. The Company is paid a service fee to clear and remove vegetation, stumps, and woody debris, material that would otherwise represent a disposal cost. The recovered organic material is then transpo

  • Concentrix Corporation logo
    PR··Technology·
    Concentrix Named a Leader in AI Enablement by Leading Analyst NelsonHall

    NEWARK, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, today announced it is positioned as a Leader in all three categories of NelsonHall's AI Enablement NEAT evaluation including Overall AI Enablement, AI Operationalization, and AI Training. As organizations move beyond experimentation and into large-scale deployment, success increasingly depends on more than AI models alone. Enterprises need the data, governance, operational frameworks, and skilled talent required to transform AI from a promising technology into a measurable business advantage. NelsonHall's AI Enablement Market Analysis highlights service provider

  • Reliance Global Group Inc. logo
    PR··Finance·
    Reliance Global Group Schedules Second Quarter 2026 Financial Results and Business Update Conference Call

    Lakewood, NJ, July 28, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("Reliance" or the "Company"), announced today that it will host a conference call Thursday, July 30, 2026, at 4:30 PM Eastern Time to discuss financial results for the second quarter 2026 and provide a business update. The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 497505. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2381/54350 or on the investor relations section of the Company’s website, https://relianceglobalgroup.com/events-and-prese

  • Cheniere Energy Inc. logo
    PR··Utilities·
    Cheniere Declares Quarterly Dividend

    Cheniere Energy, Inc. ("Cheniere") (NYSE:LNG) today announced that its Board of Directors has declared a quarterly cash dividend of $0.555 per common share payable on August 18, 2026 to shareholders of record as of the close of business on August 10, 2026. About Cheniere Cheniere Energy, Inc. is the leading producer and exporter of liquefied natural gas ("LNG") in the United States, reliably providing a clean, secure, and affordable solution to the growing global need for natural gas. Cheniere is a full-service LNG provider, with capabilities that include gas procurement and transportation, liquefaction, vessel chartering, and LNG delivery. Cheniere has one of the largest liquefaction p

  • Itron Inc. logo
    PR··Industrials·
    Itron Announces Second Quarter 2026 Financial Results

    LIBERTY LAKE, Wash, July 28, 2026 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ:ITRI), which is innovating new ways for utilities and cities to manage energy and water, announced today financial results for its second quarter ended June 30, 2026. Key results for the quarter include (compared with the second quarter of 2025): Revenue of $563 million, decreased 7%;Annual recurring revenue of $417 million, increased 21%;GAAP net income attributable to Itron, Inc. of $53 million, decreased $15 million;GAAP diluted earnings per share of $1.19, decreased $0.28 per share;Non-GAAP diluted EPS of $1.59, decreased $0.03 per share;Adjusted EBITDA of $97 million, increased 8%; andFree cash flow of $81 mill

  • OneMedNet Corp logo
    PR··Health Care·
    OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development

    MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-driven Real-World Data (RWD), today announced it has entered into an agreement to supply its regulatory-grade, multi-modal imaging-centric iRWD™ platform data for use in the development and training of a foundational AI model. Under the terms of the agreement, OneMedNet will provide high-quality, de-identified, regulatory-grade healthcare data, including millions of medical imaging and associated clinical reports, with data delivery immediately. The initial agreement has a total contract value in excess of